Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran

Zahra Alammehrjerdi 1 , * , Nadine Ezard 2 , 3 , Philip Clare 4 and Kate Dolan 1
Authors Information
1 Program of International Research and Training, National Drug and Alcohol Research Centre, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
2 Alcohol and Drug Service, St Vincent’s Hospital, Sydney, Australia
3 St Vincent’s Clinical School, University of New South Wales, Sydney, Australia
4 National Drug and Alcohol Research Centre, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e7861
  • Published Online: November 22, 2016
  • Article Type: Original Article
  • Received: July 12, 2016
  • Revised: August 28, 2016
  • Accepted: November 4, 2016
  • DOI: 10.5812/ijpbs.7861

To Cite: Alammehrjerdi Z, Ezard N, Clare P, Dolan K. Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e7861. doi: 10.5812/ijpbs.7861.

Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. United Nations Office on Drugs and Crime. World Drug Report. Vienna 2013;
  • 2. Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016; 31: 147-52[DOI][PubMed]
  • 3. How to address methamphetamine involvement in OST settings. 2011;
  • 4. Lashkaripour K, Torbati E. Methamphetamine dependency. Int J High Risk Behav Addict. 2012; 1(1): 7-8[DOI]
  • 5. Taghizadeh H, Taghizadeh F, Fathi M, Reihani P, Shirdel N, Mohadesse Rezaee S. Drug use and high risk sexual behaviours of women at a drop in centre in Mazandaran province, Iran. Iran J Psychiatry Behav Sci. 2015; 9(2)[PubMed]
  • 6. Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological burden and gender differences in methamphetamine -dependent individuals in treatment. J Psychoactive Drugs. 2016; 48(4): 261-9[DOI][PubMed]
  • 7. Hser YL, Evans E, Huang YC. Treatment outcomes among men and women methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28(1): 77-85[DOI][PubMed]
  • 8. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014; 87: 150-60[DOI][PubMed]
  • 9. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008; 27(3): 309-17[DOI][PubMed]
  • 10. Taymoori P, Pashaei T. Relapse and Risk-taking among Iranian Methamphetamine Abusers Undergoing Matrix Treatment Model. Addict Health. 2016; 8(1): 49-60[PubMed]
  • 11. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992; 87(5): 593-602[PubMed]
  • 12. Sobell LC, Sobell MB, Buchan G, Cleland P, Fedoroff I, Leo G. The reliability of the Timeline Follow Back method applied to drug, cigarette, and cannabis use. . 1996;
  • 13. Khademi MJ, Monirpoor N. Validation of relapse timeline followback interview among Narcotics Anonymous clients. J Kermanshah Univ Med Sci. 2015; 19(4): 191-6
  • 14. Azizi A, Borjali A, Golzari M. The effectiveness of emotion regulation training and cognitive therapy on the emotional and addictional problems of substance abusers. Iran J Psychiatry. 2010; 5(2): 60-5[PubMed]
  • 15. Topp L, Mattick RP. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction. 1997; 92(7): 839-45[PubMed]
  • 16. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5): 607-14[PubMed]
  • 17. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979; 9(1): 139-45[PubMed]
  • 18. Khosravi A, Mousavi SA, Chaman R, Sepidar Kish M, Ashrafi E, Khalili M. Reliability and validity of the Persian version of the World Health Organization-five well-being index. IJHS. 2015; 1(1): 17-9
  • 19. Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991; 10(5): 360-5[PubMed]
  • 20. Hogue A, Dauber S, Morgenstern J. Validation of a contemplation ladder in an adult substance use disorder sample. Psychol Addict Behav. 2010; 24(1): 137-44[DOI][PubMed]
  • 21. Amini-Lari M, Joulaei H, Faramarz H. Group cognitive-behavioural therapy for opiate use reduction in Shiraz: the first study from the Persian Gulf region of Iran. Int J High Risk Behavi Addict. 2016;
  • 22. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Subst Abuse Rehabil. 2012; 3: 37-43[DOI][PubMed]
  • 23. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Characteristics of Iranian women seeking drug treatment. J Womens Health (Larchmt). 2011; 20(11): 1687-91[DOI][PubMed]
  • 24. Alam-mehrjerdi Z, Daneshmand R, Samiei M, Samadi R, Abdollahi M, Dolan K. Women-only drug treatment services and needs in Iran: the first review of current literature. Daru. 2016; 24: 3[DOI][PubMed]
  • 25. Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med. 2008; 5(1): 24-35[PubMed]
  • 26. Greenfield SF, Trucco EM, McHugh RK, Lincoln M, Gallop RJ. The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug Alcohol Depend. 2007; 90(1): 39-47[DOI][PubMed]
  • 27. Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health. 2010; 87(3): 480-5[DOI][PubMed]
  • 28. Roshanfekr P, Noori R, Dejman M, Fathi-Geshnigani Z, Rafiey H. Drug use and sex work among at-risk women: a qualitative study of initial factors. Iran J Psychiatry Behav. 2015; 9(2)[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments